News / Events

Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms

Interpace Biosciences Announces New $7.5 Million Credit Facility with Comerica Bank

2021 Annual Meeting of Stockholders

Nov 8, 2021 • 4:00pm EDT